THE EFFECT OF IDARUBICIN MONOCLONAL ANTIBODY TREATMENT ON FIRST‐SET REJECTION OF MURINE SKIN ALLOGRAFTS
作者:
M. SMYTH,
I. MCKENZIE,
G. PIETERSZ,
期刊:
Transplantation
(OVID Available online 1989)
卷期:
Volume 48,
issue 1
页码: 77-79
ISSN:0041-1337
年代: 1989
出版商: OVID
数据来源: OVID
摘要:
Idarubicin was conjugated to anti-Ly-2.1 and anti-L3T4 monoclonal antibodies. These conjugates were used to investigate their effects on skin graft survival in mice. Several donor and recepient combinations were used so that the effect of individual or mixtures of conjugates on class I and class II antigenic differences, as well as multiple H-2 and non-H-2 antigenic differences could be studied. Ida-anti-Ly-2.1 prolonged skin grafts for class I antigenic differences. A mixture of Ida-anti-L3T4 and Ida-anti-Ly-2.1 was more effective than either conjugate alone in prolonging the survival of skin grafts with class II antigenic differences. However, idarubicin conjugates alone or in combination were unable to prolong graft survival when multiple H-2 and non-H-2 differences existed. In all models free idarubicin or unconjugated monoclonal antibody did not prolong the skin grafts.
点击下载:
PDF
(326KB)
返 回